ECB S.A.
ECB S.A., through its subsidiaries, engages in the production and sale of electricity and heat through renewable sources in Poland. The company operates heating plants, CHP plants, and biogas plants. It also provides leasing and other financial services. The company was formerly known as EC Bedzin S.A. and changed its name to ECB S.A. in May 2025. ECB S.A. was founded in 1913 and is based in Bedz… Read more
ECB S.A. (JH8) - Total Liabilities
Latest total liabilities as of September 2025: €13.71 Million EUR
Based on the latest financial reports, ECB S.A. (JH8) has total liabilities worth €13.71 Million EUR as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
ECB S.A. - Total Liabilities Trend (2021–2024)
This chart illustrates how ECB S.A.'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
ECB S.A. Competitors by Total Liabilities
The table below lists competitors of ECB S.A. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Silver Wolf Exploration Ltd
OTCQB:SWLFF
|
USA | $659.58K |
|
Kala Pharmaceuticals Inc
NASDAQ:KALA
|
USA | $1.11 Million |
|
The Calmer Co International Ltd
AU:CCO
|
Australia | AU$5.31 Million |
|
Octodec
JSE:OCT
|
South Africa | ZAC4.91 Billion |
|
Mosaic Brands Ltd
AU:MOZ
|
Australia | AU$374.12 Million |
|
AMD Industries Limited
NSE:AMDIND
|
India | ₹1.06 Billion |
|
KALA BIO, Inc.
LSE:0JQ2
|
UK | $33.69 Million |
Liability Composition Analysis (2021–2024)
This chart breaks down ECB S.A.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.64 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.67 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.40 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how ECB S.A.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for ECB S.A. (2021–2024)
The table below shows the annual total liabilities of ECB S.A. from 2021 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €11.32 Million | -98.62% |
| 2023-12-31 | €819.34 Million | +28.98% |
| 2022-12-31 | €635.22 Million | +54.34% |
| 2021-12-31 | €411.58 Million | -- |